Quetiapine Fumarate
쿠에티아핀푸마르산염
KDMF APIs중추신경계KDMF 등록
품목명 (영문)
Quetiapine Fumarate
품목명 (한글)
쿠에티아핀푸마르산염
분류
중추신경계
CAS No.
111974-72-2
KDMF 등록번호
20120713-172-I-90-05
제조원
Mylan Laboratories Limited
Qilu Tianhe Pharmaceutical Co., Ltd.
규격
USP
IUPAC Name
2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol
Synonyms
2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol
Description
Initially approved by the FDA in 1997, quetiapine is a second-generation atypical antipsychotic used in schizophrenia, major depression, and bipolar disorder. Quetiapine demonstrates a high level of therapeutic efficacy and low risk of adverse effects during long-term treatment. It is well-tolerated and a suitable option for some patients with high sensitivity to other drugs, such as Clozapine and Olanzapine.
Certificate of Analysis
If you need more information, please contact us.
규격서·시험성적서 등 추가 자료가 필요하시면 문의 시 함께 요청해 주세요. 담당자가 확인 후 회신합니다. (02-579-1056 · ace@acebiopharm.com)